𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver

✍ Scribed by J. Stenderup; J. Eriksen; S. Bols Pedersen; L. V. Christiansen

Publisher
Springer
Year
1985
Tongue
English
Weight
649 KB
Volume
28
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of diacerein in patient
Pharmacokinetics of diacerein in patients with liver cirrhosis
✍ O. Magnard; K. Louchahi; M. Tod; O. Petitjean; P. Molinier; L. Berdah; G. Perret πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 388 KB πŸ‘ 1 views

The pharmacokinetics of diacerein following a single oral dose of 50 mg was studied in 12 healthy volunteers, 10 patients with a mild liver cirrhosis (Child Pugh's grade A), and 6 patients with a more severe liver cirrhosis (Child Pugh's grade B to C). Statistical analysis using a Kruskal-Wallis tes

Pharmacokinetics of paroxetine in patien
Pharmacokinetics of paroxetine in patients with cirrhosis
✍ K. Dalhoff; T. P. Almdal; K. Bjerrum; S. Keiding; H. Mengel; J. Lund πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 419 KB

In a 14-day multiple-dose study the pharmacokinetics of paroxetine was investigated in 12 patients with alcoholic cirrhosis and in 6 subjects without liver disease. The dose of 20-30 mg paroxetine daily was adjusted to the reduction in liver function, as assessed by the galactose elimination capacit